QC
TLSA icon

Quadrature Capital’s Tiziana Life Sciences TLSA Stock Holding History

Quadrature Capital’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-37,405
Closed -$80.8K – 1649
2025
Q3 		$80.8K Buy
+37,405
New +$69.2K ﹤0.01% 902

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quadrature Capital's TLSA Position: Q4 2025 in Review

Quadrature Capital sold out of Tiziana Life Sciences (TLSA) in Q4 2025, closing a stake of 37,405 shares — an estimated $80.8K sold.

Quadrature Capital first reported a position in TLSA in Q3 2025 and held it in 1 quarter. The position peaked at $80.8K in Q3 2025. 33 funds tracked by Wall St. Rank hold TLSA as of Q4 2025.

  • Quadrature Capital reported no remaining Tiziana Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Quadrature Capital sold 37,405 Tiziana Life Sciences shares in Q4 2025, an estimated $80.8K.
  • Quadrature Capital first reported a position in Tiziana Life Sciences in Q3 2025 and held it in 1 quarter.
  • Quadrature Capital's Tiziana Life Sciences position peaked at $80.8K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q4 2025.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.